Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001213812 | SCV001385462 | uncertain significance | Congenital muscular dystrophy due to integrin alpha-7 deficiency | 2025-01-23 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 826 of the ITGA7 protein (p.Gly826Ser). This variant is present in population databases (rs761965919, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with ITGA7-related conditions. ClinVar contains an entry for this variant (Variation ID: 943593). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt ITGA7 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Revvity Omics, |
RCV001213812 | SCV003811449 | uncertain significance | Congenital muscular dystrophy due to integrin alpha-7 deficiency | 2020-07-17 | criteria provided, single submitter | clinical testing |